Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discovery of ferroptosis inducers as a new therapeutic strategy for advanced prostate cancer

January 10, 2021

New study from our lab demonstrates that ferroptosis inducers represent a new therapeutic approach for advanced prostate cancer.

https://cancerres.aacrjournals.org/content/81/6/1583.long

January 10, 2021

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousIdentification of a new serum biomarker for clinically significant prostate cancer

  • NextDr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant

Related Posts ...

Exciting News: Diana Argiles Castillo passed her qualifying examination and is now a PhD candidate

News

Exciting news: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for neuroendocrine prostate cancer.

News

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login